Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Larcher-Senn, Julian"'
Autor:
Pleyer, Lisa, Jansko‐Gadermeir, Bettina, Gassner, Franz J., Leisch, Michael, Wagner, Jakob, Zaborsky, Nadja, Dillinger, Thomas, Hutter, Sonja, Melchardt, Thomas, Egle, Alexander, Drost, Manuel, Larcher‐Senn, Julian, Greil, Richard
Publikováno v:
HemaSphere; 2023 Supplement 3, Vol. 7, p1-3, 3p
Autor:
Pleyer L; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Salzburg Cancer Research Institute (SCRI) Center for Clinical Cancer and Immunology Trials (CCCIT), Salzburg, Austria.; Cancer Cluster Salzburg (CCS), Salzburg, Austria.; 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria., Vaisband M; Salzburg Cancer Research Institute (SCRI) Center for Clinical Cancer and Immunology Trials (CCCIT), Salzburg, Austria.; Cancer Cluster Salzburg (CCS), Salzburg, Austria.; 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.; Life & Medical Sciences Institute, University of Bonn, Bonn, Germany., Drost M; Assign Data Management and Biostatistics GmbH, Innsbruck, Austria., Pfeilstöcker M; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; 3rd Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University Vienna, Vienna, Austria., Stauder R; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Austria., Heibl S; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; 4th Medical Department of Internal Medicine, Hematology, Internistic Oncology and Palliative Medicine, Klinikum Wels-Grieskirchen GmbH, Wels, Austria., Sill H; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Division of Hematology, Medical University of Graz, Graz, Austria., Girschikofsky M; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; 1st Medical Department, Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria., Stampfl-Mattersberger M; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Department of Internal Medicine 2, Wiener Gesundheitsverbund, Klinik Donaustadt, Vienna, Austria., Pichler A; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Department of Internal Medicine, Hematology and Internal Oncology, LKH Hochsteiermark, Leoben, Austria., Hartmann B; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Department of Internal Medicine 2, Landeskrankenhaus Feldkirch, Feldkirch, Austria., Petzer A; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Internal Medicine I: Medical Oncology and Hematology, Ordensklinikum Linz GmbH, Barmherzige Schwestern, Linz, Austria., Schreder M; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; 1st Department of Internal Medicine, Center for Oncology and Hematology, Wiener Gesundheitsverbund, Klinik Ottakring, Vienna, Austria., Schmitt CA; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Department of Hematology and Internal Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria.; Charité-University Medical Center, Molecular Cancer Research Center, Berlin, Germany., Vallet S; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; University Hospital Krems, Department of Internal Medicine 2, Karl Landsteiner Private University of Health Sciences, Krems, Austria., Melchardt T; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Salzburg Cancer Research Institute (SCRI) Center for Clinical Cancer and Immunology Trials (CCCIT), Salzburg, Austria.; Cancer Cluster Salzburg (CCS), Salzburg, Austria.; 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria., Zebisch A; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Division of Hematology, Medical University of Graz, Graz, Austria.; Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria., Pichler P; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Clinical Department for Internal Medicine, University Hospital St Poelten, Karl Landsteiner University of Health Sciences, St Poelten, Austria., Zaborsky N; Salzburg Cancer Research Institute (SCRI) Center for Clinical Cancer and Immunology Trials (CCCIT), Salzburg, Austria.; Cancer Cluster Salzburg (CCS), Salzburg, Austria.; 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.; Laboratory of Immunological and Molecular Cancer Research (LIMCR), Salzburg, Austria., Machherndl-Spandl S; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; 1st Medical Department, Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria., Wolf D; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Austria., Keil F; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; 3rd Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University Vienna, Vienna, Austria., Hasenauer J; Life & Medical Sciences Institute, University of Bonn, Bonn, Germany., Larcher-Senn J; Assign Data Management and Biostatistics GmbH, Innsbruck, Austria., Greil R; Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria.; Salzburg Cancer Research Institute (SCRI) Center for Clinical Cancer and Immunology Trials (CCCIT), Salzburg, Austria.; Cancer Cluster Salzburg (CCS), Salzburg, Austria.; 3rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Nov; Vol. 98 (11), pp. 1685-1698. Date of Electronic Publication: 2023 Aug 07.